View in EDS

Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.

Saved in:
Bibliographic Details
Title: Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
Authors: Duttagupta S; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Department of Microbiology & Immunology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada., Messaoudene M; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Hunter S; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Desilets A; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada., Jamal R; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada., Mihalcioiu C; Departments of Oncology and Medicine, McGill University, Montreal, Québec, Canada., Belkaid W; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Marcoux N; Hemato-Oncology Division, Centre hospitalier de l'Université de Québec, Québec City, Québec, Canada., Fidelle M; Université Paris-Saclay, U1015 INSERM, Gustave Roussy, Ligue Labellisée contre le Cancer, Villejuif, France., Suissa D; Université Paris-Saclay, U1015 INSERM, Gustave Roussy, Ligue Labellisée contre le Cancer, Villejuif, France., Ponce M; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Geiger M; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Malo J; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Piccinno G; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Punčochář M; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Filin A; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Heidrich V; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Rusu D; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Mbaye B; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Durand S; Centre de Recherche des Cordeliers, Équipe labellisée par la Ligue contre le cancer, Institut Universitaire de France, Paris, France.; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France., Ben Aissa I; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Puller V; GMT Science, Rouen, France., de Lahondès R; GMT Science, Rouen, France., Blais N; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada., Tehfe M; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada., Owen S; Departments of Oncology and Medicine, McGill University, Montreal, Québec, Canada., Bélanger K; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada., Parvathy SN; Department of Medicine, Division of Infectious Diseases, Western University, London, Ontario, Canada.; Division of Infectious Diseases, St. Joseph's Health Care, London, Ontario, Canada.; Lawson Research Institute, London, Ontario, Canada., Shieh B; Departments of Oncology and Medicine, McGill University, Montreal, Québec, Canada., Raphael J; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Ontario, Canada.; Department of Oncology, Division of Medical Oncology, Schulich School of Medicine and Dentistry at Western University, London, Ontario, Canada., Lenehan J; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Ontario, Canada.; Department of Oncology, Division of Medical Oncology, Schulich School of Medicine and Dentistry at Western University, London, Ontario, Canada., Breadner D; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Ontario, Canada.; Department of Oncology, Division of Medical Oncology, Schulich School of Medicine and Dentistry at Western University, London, Ontario, Canada., Rothenstein J; R.S. McLaughlin Durham Regional Cancer Center at Lakeridge Health, Oshawa, Ontario, Canada., Rozza N; Departments of Oncology and Medicine, McGill University, Montreal, Québec, Canada., Maillou J; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Department of Microbiology & Immunology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada., Nili S; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Prifti DK; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Pinto F; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Armanini F; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Kim-Schulze S; Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Marron TU; Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kroemer G; Centre de Recherche des Cordeliers, Équipe labellisée par la Ligue contre le cancer, Institut Universitaire de France, Paris, France.; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm, Centre de Recherche des Cordeliers, Paris, France.; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France., Derosa L; Université Paris-Saclay, U1015 INSERM, Gustave Roussy, Ligue Labellisée contre le Cancer, Villejuif, France.; Gustave Roussy Cancer Campus (GRCC), ClinicObiome, Villejuif, France., Zitvogel L; Université Paris-Saclay, U1015 INSERM, Gustave Roussy, Ligue Labellisée contre le Cancer, Villejuif, France.; Gustave Roussy Cancer Campus (GRCC), ClinicObiome, Villejuif, France., Silverman M; Department of Medicine, Division of Infectious Diseases, Western University, London, Ontario, Canada.; Division of Infectious Diseases, St. Joseph's Health Care, London, Ontario, Canada.; Lawson Research Institute, London, Ontario, Canada., Segata N; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Maleki Vareki S; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Ontario, Canada.; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.; Division of Experimental Oncology, Department of Oncology, Western University, London, Ontario, Canada.; Ontario Institute of Cancer Research, Toronto, Ontario, Canada., Routy B; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada., Elkrief A; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada. arielle.elkrief@umontreal.ca.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada. arielle.elkrief@umontreal.ca.
Source: Nature medicine [Nat Med] 2026 Apr; Vol. 32 (4), pp. 1337-1350. Date of Electronic Publication: 2026 Jan 28.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41606121
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Duttagupta+S%22">Duttagupta S</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Department of Microbiology & Immunology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Messaoudene+M%22">Messaoudene M</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Hunter+S%22">Hunter S</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Desilets+A%22">Desilets A</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Jamal+R%22">Jamal R</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Mihalcioiu+C%22">Mihalcioiu C</searchLink>; Departments of Oncology and Medicine, McGill University, Montreal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Belkaid+W%22">Belkaid W</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Marcoux+N%22">Marcoux N</searchLink>; Hemato-Oncology Division, Centre hospitalier de l'Université de Québec, Québec City, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Fidelle+M%22">Fidelle M</searchLink>; Université Paris-Saclay, U1015 INSERM, Gustave Roussy, Ligue Labellisée contre le Cancer, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Suissa+D%22">Suissa D</searchLink>; Université Paris-Saclay, U1015 INSERM, Gustave Roussy, Ligue Labellisée contre le Cancer, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Ponce+M%22">Ponce M</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Geiger+M%22">Geiger M</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Malo+J%22">Malo J</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Piccinno+G%22">Piccinno G</searchLink>; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Punčochář+M%22">Punčochář M</searchLink>; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Filin+A%22">Filin A</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Heidrich+V%22">Heidrich V</searchLink>; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Rusu+D%22">Rusu D</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Mbaye+B%22">Mbaye B</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Durand+S%22">Durand S</searchLink>; Centre de Recherche des Cordeliers, Équipe labellisée par la Ligue contre le cancer, Institut Universitaire de France, Paris, France.; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Ben+Aissa+I%22">Ben Aissa I</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Puller+V%22">Puller V</searchLink>; GMT Science, Rouen, France.<br /><searchLink fieldCode="AU" term="%22de+Lahondès+R%22">de Lahondès R</searchLink>; GMT Science, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Blais+N%22">Blais N</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Tehfe+M%22">Tehfe M</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Owen+S%22">Owen S</searchLink>; Departments of Oncology and Medicine, McGill University, Montreal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Bélanger+K%22">Bélanger K</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Parvathy+SN%22">Parvathy SN</searchLink>; Department of Medicine, Division of Infectious Diseases, Western University, London, Ontario, Canada.; Division of Infectious Diseases, St. Joseph's Health Care, London, Ontario, Canada.; Lawson Research Institute, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Shieh+B%22">Shieh B</searchLink>; Departments of Oncology and Medicine, McGill University, Montreal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Raphael+J%22">Raphael J</searchLink>; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Ontario, Canada.; Department of Oncology, Division of Medical Oncology, Schulich School of Medicine and Dentistry at Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Lenehan+J%22">Lenehan J</searchLink>; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Ontario, Canada.; Department of Oncology, Division of Medical Oncology, Schulich School of Medicine and Dentistry at Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Breadner+D%22">Breadner D</searchLink>; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Ontario, Canada.; Department of Oncology, Division of Medical Oncology, Schulich School of Medicine and Dentistry at Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Rothenstein+J%22">Rothenstein J</searchLink>; R.S. McLaughlin Durham Regional Cancer Center at Lakeridge Health, Oshawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Rozza+N%22">Rozza N</searchLink>; Departments of Oncology and Medicine, McGill University, Montreal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Maillou+J%22">Maillou J</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Department of Microbiology & Immunology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Nili+S%22">Nili S</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Prifti+DK%22">Prifti DK</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Pinto+F%22">Pinto F</searchLink>; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Armanini+F%22">Armanini F</searchLink>; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Kim-Schulze+S%22">Kim-Schulze S</searchLink>; Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Marron+TU%22">Marron TU</searchLink>; Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kroemer+G%22">Kroemer G</searchLink>; Centre de Recherche des Cordeliers, Équipe labellisée par la Ligue contre le cancer, Institut Universitaire de France, Paris, France.; Université Paris-Saclay, INSERM US23 / CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.; Université Paris Cité, Sorbonne Université, Inserm, Centre de Recherche des Cordeliers, Paris, France.; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Derosa+L%22">Derosa L</searchLink>; Université Paris-Saclay, U1015 INSERM, Gustave Roussy, Ligue Labellisée contre le Cancer, Villejuif, France.; Gustave Roussy Cancer Campus (GRCC), ClinicObiome, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Zitvogel+L%22">Zitvogel L</searchLink>; Université Paris-Saclay, U1015 INSERM, Gustave Roussy, Ligue Labellisée contre le Cancer, Villejuif, France.; Gustave Roussy Cancer Campus (GRCC), ClinicObiome, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Silverman+M%22">Silverman M</searchLink>; Department of Medicine, Division of Infectious Diseases, Western University, London, Ontario, Canada.; Division of Infectious Diseases, St. Joseph's Health Care, London, Ontario, Canada.; Lawson Research Institute, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Segata+N%22">Segata N</searchLink>; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Maleki+Vareki+S%22">Maleki Vareki S</searchLink>; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Ontario, Canada.; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.; Division of Experimental Oncology, Department of Oncology, Western University, London, Ontario, Canada.; Ontario Institute of Cancer Research, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Routy+B%22">Routy B</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Elkrief+A%22">Elkrief A</searchLink>; Axe Cancer, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada. arielle.elkrief@umontreal.ca.; Hemato-Oncology Division, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada. arielle.elkrief@umontreal.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2026 Apr; Vol. 32 (4), pp. 1337-1350. <i>Date of Electronic Publication: </i>2026 Jan 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41606121
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-025-04186-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1337
    Titles:
      – TitleFull: Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Duttagupta S
      – PersonEntity:
          Name:
            NameFull: Messaoudene M
      – PersonEntity:
          Name:
            NameFull: Hunter S
      – PersonEntity:
          Name:
            NameFull: Desilets A
      – PersonEntity:
          Name:
            NameFull: Jamal R
      – PersonEntity:
          Name:
            NameFull: Mihalcioiu C
      – PersonEntity:
          Name:
            NameFull: Belkaid W
      – PersonEntity:
          Name:
            NameFull: Marcoux N
      – PersonEntity:
          Name:
            NameFull: Fidelle M
      – PersonEntity:
          Name:
            NameFull: Suissa D
      – PersonEntity:
          Name:
            NameFull: Ponce M
      – PersonEntity:
          Name:
            NameFull: Geiger M
      – PersonEntity:
          Name:
            NameFull: Malo J
      – PersonEntity:
          Name:
            NameFull: Piccinno G
      – PersonEntity:
          Name:
            NameFull: Punčochář M
      – PersonEntity:
          Name:
            NameFull: Filin A
      – PersonEntity:
          Name:
            NameFull: Heidrich V
      – PersonEntity:
          Name:
            NameFull: Rusu D
      – PersonEntity:
          Name:
            NameFull: Mbaye B
      – PersonEntity:
          Name:
            NameFull: Durand S
      – PersonEntity:
          Name:
            NameFull: Ben Aissa I
      – PersonEntity:
          Name:
            NameFull: Puller V
      – PersonEntity:
          Name:
            NameFull: de Lahondès R
      – PersonEntity:
          Name:
            NameFull: Blais N
      – PersonEntity:
          Name:
            NameFull: Tehfe M
      – PersonEntity:
          Name:
            NameFull: Owen S
      – PersonEntity:
          Name:
            NameFull: Bélanger K
      – PersonEntity:
          Name:
            NameFull: Parvathy SN
      – PersonEntity:
          Name:
            NameFull: Shieh B
      – PersonEntity:
          Name:
            NameFull: Raphael J
      – PersonEntity:
          Name:
            NameFull: Lenehan J
      – PersonEntity:
          Name:
            NameFull: Breadner D
      – PersonEntity:
          Name:
            NameFull: Rothenstein J
      – PersonEntity:
          Name:
            NameFull: Rozza N
      – PersonEntity:
          Name:
            NameFull: Maillou J
      – PersonEntity:
          Name:
            NameFull: Nili S
      – PersonEntity:
          Name:
            NameFull: Prifti DK
      – PersonEntity:
          Name:
            NameFull: Pinto F
      – PersonEntity:
          Name:
            NameFull: Armanini F
      – PersonEntity:
          Name:
            NameFull: Kim-Schulze S
      – PersonEntity:
          Name:
            NameFull: Marron TU
      – PersonEntity:
          Name:
            NameFull: Kroemer G
      – PersonEntity:
          Name:
            NameFull: Derosa L
      – PersonEntity:
          Name:
            NameFull: Zitvogel L
      – PersonEntity:
          Name:
            NameFull: Silverman M
      – PersonEntity:
          Name:
            NameFull: Segata N
      – PersonEntity:
          Name:
            NameFull: Maleki Vareki S
      – PersonEntity:
          Name:
            NameFull: Routy B
      – PersonEntity:
          Name:
            NameFull: Elkrief A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1